Corvus Pharmaceuticals
CRVS
CRVS
52 hedge funds and large institutions have $44.6M invested in Corvus Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less call options, than puts
Call options by funds: $266K | Put options by funds: $272K
2.79% less ownership
Funds ownership: 44.65% → 41.86% (-2.8%)
Holders
52
Holding in Top 10
1
Calls
$266K
Puts
$272K
Top Buyers
| 1 | +$4.82M | |
| 2 | +$685K | |
| 3 | +$469K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$423K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
+$229K |
Top Sellers
| 1 | -$4.9M | |
| 2 | -$1.85M | |
| 3 | -$499K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$168K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$115K |